💊 Sanofi goes virtual for vaccine making; Moderna may make Ebola vaccines

#203 | Magnetic bacteria to treat cancer

Hello, and welcome back to The Kable.

Indian pharma's love affair with the US FDA continues unabated. The agency sent a torrid Form 483 to Jubilant over QC issues at its plant in Sikanderpur Bhainswal, Uttaranchal. The inspection report flagged multiple failures and review lapses and said lab control procedures weren't followed either.

Also at the receiving end of the agency's affections was Glenmark Pharma. Glenmark received an import alert from the US FDA for its manufacturing plant at India's pharma manufacturing hub in Baddi, Himachal Pradesh, following an inspection in June this year.

Separately, the US FDA also gave Zydus Lifesciences the go-ahead for the market launch of its Micafungin injection to treat fungal infections.

The Ebola outbreak in Uganda just got a little worse with 6 school children attending three different schools in the capital Kampala, among the newest lot of affected patients. In the past 24 hours, 12 new patients have been identified. The WHO has deployed cars to help with the situation. 22 cars.